{"id":"W1964185052","doi":"10.1007/s10637-010-9399-1","title":"A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction","year":2010,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Medicine; Population; Response Evaluation Criteria in Solid Tumors; Internal medicine; Clinical endpoint; Gastroenterology; Phases of clinical research; Doxorubicin; Chemotherapy; Adenocarcinoma; Surgery; Esophagus; Progressive disease; Oncology; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002141384,0.0001482466,0.0002739447,0.0002116923,0.0000392554,0.000006897221,0.00009643167,0.00004463815,0.00002634484],"category_scores_gemma":[0.0001598526,0.0001016073,0.00002909549,0.0004667338,0.0001890847,0.0001220488,0.00005526442,0.0003643672,7.875475e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009109238,"about_ca_system_score_gemma":0.0004503657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009519833,"about_ca_topic_score_gemma":0.0005174655,"domain_scores_codex":[0.9983971,0.00006729565,0.0003926016,0.0002704022,0.0006577692,0.0002147926],"domain_scores_gemma":[0.9992583,0.00006305828,0.0001828687,0.0002154829,0.0001179533,0.0001623802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001289699,0.001630354,0.9921216,0.00005596105,0.00002969836,0.00001953116,0.001319771,0.00009823494,0.0006088818,0.0001317147,0.00001689647,0.002677636],"study_design_scores_gemma":[0.02746983,0.00338679,0.9581348,0.000120213,0.00002708713,0.000003049591,0.0002502149,0.00008891109,0.01013167,0.0003271627,0.000001945568,0.00005831354],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969662,0.001086592,0.000002284782,0.0003481326,0.00005121277,0.001503221,0.00001085948,0.000007165334,0.00002427517],"genre_scores_gemma":[0.9986595,0.000002365068,0.001100957,0.0000576267,0.00004121948,0.00005138132,0.00002610733,0.00001585235,0.0000450079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0339868,"threshold_uncertainty_score":0.4143426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007041558149605497,"score_gpt":0.2578805014282209,"score_spread":0.2508389432786154,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}